Thank you for educating people about EDKA. I almost lost my husband to this last week. He had no symptoms until he passed out. It was caused by his low carb diet mixed with the prescribe Jardiance. Thankfully, the ER doctor diagnosed it correctly and the ICU administered the correct treatment. They discontinued the Jardiance.
The risk of euglycemic DKA is increased with theses agents, but if patient selection and education on management of use of SGLT-2-I during illness or around the time of surgery the risk can be reduced.
Dka due to sglt2 inhibitors are easy target to the covid virus because the immune system is suppressed because of the acidosis and the drug has to be treated with caution in this covid pandemic.
At this time the same level of caution in selecting the ideal candidate for the drug therapy remains in order to reduce the risk of euglycemic DKA. Patients may have slight enhancement of infection due to side-effects of DKA, but no different than DKA in type-1 DM using insulin.
Thank you for educating people about EDKA. I almost lost my husband to this last week. He had no symptoms until he passed out. It was caused by his low carb diet mixed with the prescribe Jardiance. Thankfully, the ER doctor diagnosed it correctly and the ICU administered the correct treatment. They discontinued the Jardiance.
Hooray!
What was his glucose level, and what treatment did he receive?
Could the problem been the Jardiance alone, since many people seem to thrive on low carb diets for a long time
This is very good thankyou
Exactly what issue are SGLT2's attempting to resolve?
Actually they do have increased urination and thirst.( that is the basic side effect of sglt-2 inhibtors)
Does they increase the risk....???
The risk of euglycemic DKA is increased with theses agents, but if patient selection and education on management of use of SGLT-2-I during illness or around the time of surgery the risk can be reduced.
Dka due to sglt2 inhibitors are easy target to the covid virus because the immune system is suppressed because of the acidosis and the drug has to be treated with caution in this covid pandemic.
At this time the same level of caution in selecting the ideal candidate for the drug therapy remains in order to reduce the risk of euglycemic DKA. Patients may have slight enhancement of infection due to side-effects of DKA, but no different than DKA in type-1 DM using insulin.